Vaccines and biologics
- PMID: 24845388
- DOI: 10.1136/annrheumdis-2014-205246
Vaccines and biologics
Abstract
Patients with autoimmune rheumatic diseases are more susceptible to infectious complications during the course of their disease. The introduction of biologics has been a major achievement in treating these diseases, but an increased risk of infection associated with these therapies has become evident. Some infections can be prevented by vaccination and it is clearly worthwhile considering which immunisations would be sensible and practicable for these patients. To date no formal specific recommendations for patients on biologics have been published. A search was made of Medline (via PubMed) from 1970 to January 2014 to provide results. This review aims to provide a systematic analysis of the data about vaccines and biologics and considers recommendations for vaccination in adult patients with autoimmune rheumatic diseases treated with biologics.
Keywords: biologics; vaccines.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Similar articles
-
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.Autoimmun Rev. 2011 Apr;10(6):341-52. doi: 10.1016/j.autrev.2010.12.003. Epub 2010 Dec 20. Autoimmun Rev. 2011. PMID: 21182987 Review.
-
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.Ann Rheum Dis. 2011 Mar;70(3):414-22. doi: 10.1136/ard.2010.137216. Epub 2010 Dec 3. Ann Rheum Dis. 2011. PMID: 21131643
-
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.Ann Rheum Dis. 2020 Jan;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882. Epub 2019 Aug 14. Ann Rheum Dis. 2020. PMID: 31413005
-
[Vaccinations in patients with autoimmune inflammatory rheumatic diseases--EULAR recommendations for pediatric and adult patients].Med Monatsschr Pharm. 2012 Oct;35(10):353-64; quiz 365-6. Med Monatsschr Pharm. 2012. PMID: 23094578 Review. German.
-
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases.Swiss Med Wkly. 2015 Jul 28;145:w14159. doi: 10.4414/smw.2015.14159. eCollection 2015. Swiss Med Wkly. 2015. PMID: 26218860
Cited by
-
Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies.Chem Sci. 2021 Jun 14;12(28):9759-9769. doi: 10.1039/d1sc01748a. eCollection 2021 Jul 21. Chem Sci. 2021. PMID: 34349949 Free PMC article.
-
Opportunities for pharmacists in vaccinating higher-risk populations.Can Pharm J (Ott). 2019 Oct 16;152(6):418-423. doi: 10.1177/1715163519877898. eCollection 2019 Nov-Dec. Can Pharm J (Ott). 2019. PMID: 31762856 Free PMC article. Review. No abstract available.
-
Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach.PLoS One. 2019 Oct 4;14(10):e0223594. doi: 10.1371/journal.pone.0223594. eCollection 2019. PLoS One. 2019. PMID: 31584996 Free PMC article.
-
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy.PLoS Biol. 2019 Jun 13;17(6):e3000286. doi: 10.1371/journal.pbio.3000286. eCollection 2019 Jun. PLoS Biol. 2019. PMID: 31194726 Free PMC article.
-
Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects.PLoS One. 2019 May 28;14(5):e0217221. doi: 10.1371/journal.pone.0217221. eCollection 2019. PLoS One. 2019. PMID: 31136605 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
